Most of the bone formation and mineralization histomorphometric variables were significantly higher for teriparatide- than strontium ranelate-treated women at both the periosteal and endosteal cortices. These effects on bone formation may underline the improvement in bone quality in patients with osteoporosis treated with teriparatide.